Monding, Angelika G.

HRN: 27-68-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2025
CEFUROXIME 1.5GM (VIAL)
08/22/2025
08/22/2025
IV
1.5 Grams
PTOR
OR Prophylaxis
Checking Initial Appropriateness 
08/22/2025
CEFUROXIME 1.5GM (VIAL)
08/22/2025
08/23/2025
IV
1.5gm
Q8hr X 2 Doses
Sp Pelvic Lap
Checking Initial Appropriateness 
08/23/2025
CEFUROXIME 500MG (TAB)
08/23/2025
08/30/2025
ORAL
500mg
BID
S/P Ex Lap
Checking Initial Appropriateness 
08/25/2025
CEFUROXIME 500MG (TAB)
08/25/2025
08/29/2025
PO
500mg
BID
SP Ex Lap
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: